Waycross Partners, LLC Exact Sciences Corp Transaction History
Waycross Partners, LLC
- $1.06 Billion
- Q2 2025
A detailed history of Waycross Partners, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Waycross Partners, LLC holds 25,000 shares of EXAS stock, worth $1.17 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
25,000Holding current value
$1.17 Million% of portfolio
0.13%Shares
1 transactions
Others Institutions Holding EXAS
# of Institutions
636Shares Held
157MCall Options Held
1.64MPut Options Held
1.5M-
Capital World Investors Los Angeles, CA17.8MShares$835 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$825 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12.5MShares$585 Million0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$565 Million0.01% of portfolio
-
State Street Corp Boston, MA6.61MShares$310 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $8.28B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...